An Open-Label Phase II Study in Anti-GBM Disease (Goodpasture's Disease) With Adverse Renal Prognosis to Evaluate the Efficacy and Safety of IdeS --GOOD-IDES
Phase of Trial: Phase II
Latest Information Update: 14 Nov 2017
At a glance
- Drugs IdeS (Primary)
- Indications Anti glomerular basement membrane disease
- Focus Proof of concept; Therapeutic Use
- Acronyms GOOD-IDES
- 14 Nov 2017 According to a Hansa Medical AB media release, till date 5 patients had been included in this study and limited follow-up data from three of these five patients is now available.
- 20 Jun 2017 According to a Hansa Medical AB media release, the first patient is treated in this study.
- 15 May 2017 Status changed from planning to recruiting.